BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 9269786)

  • 21. Clinico-biological features and prognostic significance of PML/RARalpha isoforms in adult patients with acute promyelocytic leukemia treated with all trans retinoic acid (ATRA) and chemotherapy.
    Gupta V; Yib QL; Brandwein J; Chun K; Lipton JH; Messner H; Schuh AC; Wells RA; Minden MD; Kamel-Reidc S
    Leuk Lymphoma; 2004 Mar; 45(3):469-80. PubMed ID: 15160908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RAR alpha1/RAR alpha2-PML mRNA expression in acute promyelocytic leukemia cells: a molecular and laboratory-clinical correlative study.
    Li YP; Andersen J; Zelent A; Rao S; Paietta E; Tallman MS; Wiernik PH; Gallagher RE
    Blood; 1997 Jul; 90(1):306-12. PubMed ID: 9207466
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A retinoid-resistant acute promyelocytic leukemia subclone expresses a dominant negative PML-RAR alpha mutation.
    Shao W; Benedetti L; Lamph WW; Nervi C; Miller WH
    Blood; 1997 Jun; 89(12):4282-9. PubMed ID: 9192750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Secondary cytogenetic changes in acute promyelocytic leukemia--prognostic importance in patients treated with chemotherapy alone and association with the intron 3 breakpoint of the PML gene: a Cancer and Leukemia Group B study.
    Slack JL; Arthur DC; Lawrence D; Mrózek K; Mayer RJ; Davey FR; Tantravahi R; Pettenati MJ; Bigner S; Carroll AJ; Rao KW; Schiffer CA; Bloomfield CD
    J Clin Oncol; 1997 May; 15(5):1786-95. PubMed ID: 9164186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Variant complex translocations involving chromosomes 1, 9, 9, 15 and 17 in acute promyelocytic leukemia without RAR alpha/PML gene fusion rearrangement.
    Gogineni SK; Shah HO; Chester M; Lin JH; Garrison M; Alidina A; Bayani E; Verma RS
    Leukemia; 1997 Apr; 11(4):514-8. PubMed ID: 9096691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The PML/RAR alpha fusion gene in the diagnosis and monitoring of acute promyelocytic leukemia.
    Diverio D; Riccioni R; Mandelli F; Lo Coco F
    Haematologica; 1995; 80(2):155-60. PubMed ID: 7628753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of PML-retinoic acid receptor-alpha fusion transcripts in acute promyelocytic leukemia with trisomy 8 but without t(15;17).
    Ikeda K; Sasaki K; Tasaka T; Nagai M; Kawanishi K; Takahara J; Irino S
    Am J Hematol; 1994 Mar; 45(3):212-6. PubMed ID: 8296791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Presenting white blood cell count and kinetics of molecular remission predict prognosis in acute promyelocytic leukemia treated with all-trans retinoic acid: result of the Randomized MRC Trial.
    Burnett AK; Grimwade D; Solomon E; Wheatley K; Goldstone AH
    Blood; 1999 Jun; 93(12):4131-43. PubMed ID: 10361110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnosis and follow-up of acute promyelocytic leukemia by detection of PML-RAR alpha gene rearrangement.
    Gau JP; Young JH; Lin TH; Yang YS
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Mar; 63(3):175-81. PubMed ID: 10746412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A study on the relationship between morphology and gene heterogeneity in acute promyelocytic leukemia].
    Xiong S; Chen Z; Huang W
    Zhonghua Nei Ke Za Zhi; 1995 Mar; 34(3):165-8. PubMed ID: 7648936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The PML-RAR alpha transcript in long-term follow-up of acute promyelocytic leukemia patients.
    Gameiro P; Vieira S; Carrara P; Silva AL; Diamond J; Botelho de Sousa A; Mehta AB; Prentice HG; Guimarães JE; Hoffbrand AV; Foroni L; Parreira A
    Haematologica; 2001 Jun; 86(6):577-85. PubMed ID: 11418366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pretreatment characteristics and clinical outcome of acute promyelocytic leukaemia patients according to the PML-RAR alpha isoforms: a study of the PETHEMA group.
    González M; Barragán E; Bolufer P; Chillón C; Colomer D; Borstein R; Calasanz MJ; Gómez-Casares MT; Villegas A; Marugán I; Román J; Martín G; Rayón C; Debén G; Tormo M; Díaz-Mediavilla J; Esteve J; González-San Miguel J; Rivas C; Pérez-Equiza K; García-Sanz R; Capote FJ; Ribera JM; Arias J; León A; Sanz MA;
    Br J Haematol; 2001 Jul; 114(1):99-103. PubMed ID: 11472351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel, non-nested reverse-transcriptase polymerase chain reaction (RT-PCR) test for the detection of the t(15;17) translocation: a comparative study of RT-PCR cytogenetics, and fluorescence In situ hybridization.
    Rennert H; Golde T; Wilson RB; Spitalnik SL; Van Deerlin VM; Leonard DG
    Mol Diagn; 1999 Sep; 4(3):195-209. PubMed ID: 10553020
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutations in the E-domain of RAR portion of the PML/RAR chimeric gene may confer clinical resistance to all-trans retinoic acid in acute promyelocytic leukemia.
    Imaizumi M; Suzuki H; Yoshinari M; Sato A; Saito T; Sugawara A; Tsuchiya S; Hatae Y; Fujimoto T; Kakizuka A; Konno T; Iinuma K
    Blood; 1998 Jul; 92(2):374-82. PubMed ID: 9657734
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term survival and prognostic study in acute promyelocytic leukemia treated with all-trans-retinoic acid, chemotherapy, and As2O3: an experience of 120 patients at a single institution.
    Hu J; Shen ZX; Sun GL; Chen SJ; Wang ZY; Chen Z
    Int J Hematol; 1999 Dec; 70(4):248-60. PubMed ID: 10643151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Detection of the PML/RAR alpha rearrangement in acute promyelocytic leukemia using a reverse PCR method].
    Barragán E; Bonanad S; López JA; Martín G; Martínez J; Sanz GF; Gomis F; Pérez ML; Senent ML; Larrea L; Bolufer P; Sanz MA
    Sangre (Barc); 1996 Jun; 41(3):189-94. PubMed ID: 8755206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unexpected heterogeneity of PML/RAR alpha fused mRNA detected by nested polymerase chain reaction in acute promyelocytic leukemia.
    Matsuoka A; Miyamura K; Emi N; Tahara T; Tanimoto M; Naoe T; Ohno R; Kakizuka A; Evans RM; Saito H
    Leukemia; 1993 Aug; 7(8):1151-5. PubMed ID: 8394480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. AM580, a stable benzoic derivative of retinoic acid, has powerful and selective cyto-differentiating effects on acute promyelocytic leukemia cells.
    Gianní M; Li Calzi M; Terao M; Guiso G; Caccia S; Barbui T; Rambaldi A; Garattini E
    Blood; 1996 Feb; 87(4):1520-31. PubMed ID: 8608243
    [TBL] [Abstract][Full Text] [Related]  

  • 39. C-fms expression correlates with monocytic differentiation in PML-RAR alpha+ acute promyelocytic leukemia.
    Riccioni R; Saulle E; Militi S; Sposi NM; Gualtiero M; Mauro N; Mancini M; Diverio D; Lo Coco F; Peschle C; Testa U
    Leukemia; 2003 Jan; 17(1):98-113. PubMed ID: 12529666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retinoic acid regulatory pathways, chromosomal translocations, and acute promyelocytic leukemia.
    Chen Z; Tong JH; Dong S; Zhu J; Wang ZY; Chen SJ
    Genes Chromosomes Cancer; 1996 Mar; 15(3):147-56. PubMed ID: 8721678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.